Your Notifications
All done, no notifications
Dr. Professor Amos Toren

Dr. Professor Amos Toren

Hematologist

, Ramat Gan, Israel

30 Years of experience

Speaks: Hebrew , English

USD 3000 USD 2800 for video consultation

Chat
Book Video Consultation

About Dr. Professor Amos Toren

  • Prof. Amos Toren is the Director of the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center, Israel’s leading center for childhood cancer treatment.
  • Prof. Toren holds triple board certifications in pediatrics, general hematology, and pediatric hemato-oncology, and has more than 30 years of clinical and research expertise.
  • A former two-term Head of the Hematology Division at the Tel Aviv University School of Medicine, Prof. Toren is recognized internationally for his contributions to pediatric cancer care and research.
  • His primary research areas include CAR T-cell therapy for relapsed/resistant CD19-expressing leukemias and lymphomas, the effects of cannabinoids on pediatric tumors, cytokine-induced killer cells, and pediatric brain tumor biology.
  • Under his leadership, the Pediatric Hemato-Oncology Department at Sheba Medical Center serves not only children but also young adults (up to age 30) with pediatric-type solid tumors.
  • The department maintains strong collaborations with top global institutions, including St. Jude Children’s Research Hospital, the NIH, and St. Anna Children’s Hospital in Austria, positioning it at the forefront of pediatric oncology research and innovation.

Conditions treated by Dr. Amos Toren

  • Pediatric Oncology
  • Hematological Diseases
  • Immune Deficiencies
  • Hemato-Oncology
  • Chronic Blood Disorders
  • Stem Cell Transplantation
  • Bone Marrow Transplantation
  • Lymphoma
  • Thalassemia
  • Inborn Errors Of Metabolism
  • Bone Marrow Failure
  • Cancer
  • Chemotherapy
  • Hematology
  • Leukemia

Area of Interest

  • Pediatrics General Hematology
  • Pediatric Hemato-Oncology

Qualification

  • MBBS, The School of Medicine, Tel-Aviv University
  • Degree of M.D. Residency, Department of Pediatrics, Sheba Medical Center, Registered Specialist in Pediatrics
  • PhD the Faculty of Medicine, Department of Human Genetics, Tel-Aviv University
  • MHA, Recanati School of Business, Tel-Aviv University

Work Experiences

  • Director of the Pediatric Hemato-Oncology and BMT Division
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Amos Toren on our platform

Consult Online

CERTIFICATIONS (2)

  • Pediatric Hemato-Oncology (Board certified)
  • Bone Marrow Transplantation (Board certified)

MEMBERSHIPS (9)

  • The Israeli Pediatric Society (Member)
  • The Israeli Society of Haematology (Member)
  • The Israeli Society of Pediatric Haematology-Oncology (ISPHO) (Member)
  • The European Society of Pediatric Haematology (ESPHI) (Member)
  • The European Group for Blood and Marrow Transplantation (EBMT) (Member)
  • The American Society of Haematology (ASH) (Member)
  • The Children's Oncology Group (COG) (Member)
  • The Center for international Blood and Marrow transplant research (CIBMTR) (Member)
  • Member of the Ministry of Health Cord Blood Committee (Member)

RESEARCH PAPERS AND PUBLICATIONS (3)

  • Ziv A, Dardik R, Yacobovich J, Uziel Y, Haviv R, Avishai E, Kenet G, Toren A, Barel O, Barg AA. Atypical Presentations of Pediatric-acquired Thrombotic Thrombocytopenic Purpura. Journal of Pediatric Haematology/Oncology. 2024 Aug 1;46(6):306-10.
  • Gross G, Alkadieri S, Meir A, Itzhaki O, Aharoni-Tevet Y, Ben Yosef S, Zenab A, Shbiro L, Toren A, Yardeni T, Jacoby E. Improved CAR-T cell activity associated with increased mitochondrial function primed by galactose. Leukemia. 2024 Jul;38(7):1534-40.
  • Lankester AC, Neven B, Mahlaoui N, von Asmuth EG, Courteille V, Alligon M, Albert MH, Serra IB, Bader P, Balashov D, Beier R. Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort. Journal of Allergy and Clinical Immunology. 2022 May 1;149(5):1744-54.

Share Your Experience about Dr. Professor Amos Toren

Write Your Review

PROCEDURES

  • Bone Marrow Transplant
  • Castleman Disease Treatment

FREQUENTLY ASKED QUESTIONS

Is Doctor Amos Toren doing teleconsultation on the MediGence platform?

Dr. Amos Toren is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I book my procedure with the doctor post-consultation?

Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Can you get an estimate for the procedure?

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Hematologist

What is Pediatric Hemato-Oncology?

Pediatric Hemato-Oncology is a medical speciality that focuses on diagnosing and treating blood disorders (haematology) and cancers (oncology) in children, adolescents, and young adults. This includes leukaemia, lymphoma, solid tumours, and blood diseases like anaemia or clotting disorders.

What are the most common childhood cancers?
  • Leukaemia (especially acute lymphoblastic leukaemia - ALL)
  • Brain and central nervous system tumours
  • Lymphomas (Hodgkin and non-Hodgkin)
  • Neuroblastoma
  • Wilms tumor
  • Rhabdomyosarcoma
  • Bone cancers (e.g., osteosarcoma, Ewing sarcoma)
What symptoms may suggest a blood disorder or cancer in a child?
  • Unexplained fatigue or weakness
  • Frequent infections
  • Easy bruising or bleeding
  • Persistent fever or night sweats
  • Swollen lymph nodes
  • Bone or joint pain
  • Weight loss or loss of appetite
  • Headaches or changes in vision
What are the treatment options for pediatric cancers?

Treatment varies based on the type and stage of cancer, and may include:

  • Chemotherapy
  • Radiation therapy
  • Surgery
  • Targeted therapies
  • Immunotherapy (including CAR T-cell therapy)
  • Bone marrow/stem cell transplantation
What is CAR T-cell therapy?

CAR T-cell therapy is an advanced immunotherapy that involves modifying a patient’s T-cells to recognise and attack cancer cells, especially effective in certain types of relapsed or resistant leukaemia and lymphoma.

Is childhood cancer curable?

Yes, many childhood cancers have high cure rates, especially when diagnosed early and treated at specialised centres. Advances in research and personalised medicine have significantly improved survival rates.

Reviewer

Dr. Vishwas Kaushik

MBBS, MD

5 Years of Experience

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries. View More

Author

Dr. Shagufta Parveen

Doctor of Pharmacy

1.5 Years of Experience

Dr. Shagufta Parveen is a medical and scientific content writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad. During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources. Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.. View More